It's down 40% this year.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

This company is in the midst of a major turnaround, but results have remained sluggish. Headwinds may subside this year, leading to strong earnings-per-share growth. The stock looks very attractive at ...

Keysight Technologies surged 114% in a year, fueled by AI data center exposure, but fundamentals lag market expectations. See ...

Each style of stock has its place in investor portfolios, though weighting may need to change with the economy.

Edwards Lifesciences remains a high-quality business with a wide economic moat , but the stock is still overvalued. Click ...

As of Thursday, May 28, Hormel Foods Corporation’s HRL share price has surged by 8.90%, which has investors questioning if ...

Palantir has produced some very impressive financial results over the last few years. CEO Alex Karp has focused on key product improvements instead of trying to increase sales with more marketing.

As of Monday, May 18, Tenaya Therapeutics, Inc.’s TNYA share price has dipped by 9.02%, which has investors questioning if ...